[PDF] Top 20 Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Has 10000 "Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload" found on our website. Below are the top 20 most common "Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload".
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
... CHARACTERISTICS AND CLINICAL COURSE. The baseline characteristics of the patients with or without recent volume overload were similar with respect to ejection ... Voir le document complet
13
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
... As in other HFrEF trials examining the effect of different heart failure medications on SBP, patients in RALES and EMPHASIS-HF with the lowest baseline SBP experienced an ... Voir le document complet
12
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
... ]. In this study, we showed that patients with higher doses of loop diuretics showed signs of more severe heart fail- ure and ...dosing and (percentage of) target dose of ... Voir le document complet
13
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
... Introduction Besides the risk for mortality and recurrent hospitalizations, patients with heart failure with reduced ejection fraction HFrEF also suffer from impaired health status.1,2 I[r] ... Voir le document complet
11
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
... DESIGN AND PERFORMANCE. Several aspects of the BeAT-HF trial design and performance were novel and were optimized through collaboration with the FDA’s Center for Devices and ... Voir le document complet
14
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
... site, and all patients provided written informed ...Study Patients Participants included patients ≥18 years or older who had chronic heart failure (New York Heart ... Voir le document complet
35
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
... deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions in France or abroad, or from public or private research ... Voir le document complet
25
Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge
... sium, and creatinine measurements was able to capture a substantial number of clinically relevant cardiorenal and electrolyte events which are frequently overlooked and potentially ...inhibitors ... Voir le document complet
8
Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
... accurate and reproducible to be used in isolation for stratifying risk in an individual patient with ...trials in HFpEF identi fied many echocardiographic variables that might provide ... Voir le document complet
14
The continuous heart failure spectrum: moving beyond an ejection fraction classification
... used heart failure (HF) patients with low left ventricular ejection fraction (LVEF) to select study pop- ulations with high risk to enhance statistical ...LVEF in ... Voir le document complet
12
Tumour biomarkers: association with heart failure outcomes.
... studies), and follow-up was mainly aimed to describe CV events and mortality, while cancer events and mortality were not stringently ...ethnicities and populations beyond Europe. The majority ... Voir le document complet
13
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction
... ePVS and Hakim-derived ePVS on top of clinical and routine biological covariates (including natriuretic ...ePVS in patients with HFpEF. The main difference in the aforementioned ... Voir le document complet
28
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial
... of patients less prone to develop hyperkalaemia and the proto- col included recommendations to manage hyperkalaemia, both of which may have reduced the impact of hyperkalaemia relative to ... Voir le document complet
10
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets.
... ventricular ejection fraction (LVEF) ≤40% and/or B-type natri- uretic peptide (BNP) >400 pg/mL or N-terminal pro-B-type natriuretic peptide (NT-proBNP) >2000 pg/mL as well as were not yet ... Voir le document complet
12
Circulating neuregulin1-beta in heart failure with preserved and reduced left ventricular ejection fraction
... 1-β in HFrEF compared with HFpEF and controls which is counterin- tuitive as the neurohormonal activation is greater in ...Our patients with HFrEF all had severe HF referred for ... Voir le document complet
12
Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction
... examination in patients with acute heart failure: ...Echocardiography in Patients With Heart ...Ultrasound in Ambulatory Patients With ... Voir le document complet
30
Changes in mitral regurgitation and left ventricular geometry during exercise affect exercise capacity in patients with systolic heart failure.
... echocardiography with a matrix-array transducer (X3-1, ...scan volume. A real-time three-dimensional data set equipped with a wide-angle acquisition (93 × 808) mode could obtain four wedge-shaped ... Voir le document complet
7
Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach
... mechanisms and risk factors causing RVD and pulmonary vascular (PV) disease in HFpEF are not fully elucidated and constitute a topic of great interest and ongoing ...research. In ... Voir le document complet
20
A personalized algorithm-based discharge checklist in patients with acute heart failure
... HF and the uptitration of evidence-based therapies, our personalized discharge CL may be less effective in patients with heart failure with preserved ejection ... Voir le document complet
29
Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
... of heart failure with preserved ejection fraction The four descriptive models of HFpEF were used for which the FC-HF was required for all (Figure ...1). In addition, in ... Voir le document complet
11
Sujets connexes